SETBP1 and chronic myelogenous leukemia, BCR-ABL1 positive: SETBP1 overexpression was also observed in some CML advanced phase/blast crisis patients [15] in which PP2A activity was shown to be inhibited maybe through an increased SET expression induced by BCR-ABL1 [57].